Viatris Share Price Today (NASDAQ: VTRS)

Name: Viatris Share Price (NASDAQ: VTRS) - Stock Quote, Live Chart
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Viatris share price is $8.29 & ₹707.05 as on 25 May 2025, 2.30 'hrs' IST

$8.29

▲

-0.21

(-2.47%)

Market is closed - opens 7 PM, 27 May 2025

View live Viatris share price in Dollar and Rupees. Guide to invest in Viatris stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Viatris, along with analyst recommendations, forecasts, and comprehensive financials.

Viatris share price movements

Today's Low: $8.20
Today's High: $8.30
$8.29
1.15%
Downside
Day's Volatility :1.27%
Upside
0.12%
52 Weeks Low: $6.85
52 Weeks High: $13.55
$8.29
17.37%
Downside
52 Weeks Volatility :49.45%
Upside
38.82%

Viatris (VTRS) Returns

Period	Viatris Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-25.59%	-10.8%	0.0%
6 Months	-36.56%	-9.4%	0.0%
1 Year	-18.59%	-9.9%	0.0%
3 Years	-28.42%	-0.3%	-1.3%

Viatris (VTRS) Key Statistics

in dollars & INR

Previous Close	$8.5
Open	$8.265
Today's High	$8.3
Today's Low	$8.195
Market Capitalization	$10.0B
Today's Volume	$17.1M
52 Week High	$13.55
52 Week Low	$6.85
Revenue TTM	$14.3B
EBITDA	$4.2B
Earnings Per Share (EPS)	$-3.18
Dividend Yield	5.66%
Profit Margin	-26.45%
Quarterly Earnings Growth YOY	-0.71%
Return On Equity TTM	-21.25%

How to invest in Viatris Stock (VTRS) from India?

It is very easy for Indian residents to invest directly in Viatris from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Viatris stock in both Indian Rupees (INR) and US Dollars (USD). Search for Viatris or VTRS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Viatris or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Viatris shares which would translate to 0.103 fractional shares of Viatris as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Viatris, in just a few clicks!

Returns in Viatris (VTRS) for Indian investors in Rupees

The Viatris stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Viatris investment value today

Current value as on today

₹81,203

Returns

₹18,797

(-18.8%)

Returns from Viatris Stock

₹21,273 (-21.27%)

Dollar Returns

₹2,475 (+2.48%)

Indian investors sentiment towards Viatris (VTRS)

88%

Period: Apr 23, 2025 to May 23, 2025. Change in 30 Days versus previous period

Search interest for Viatris Stock from India on INDmoney has increased by 88% in the last 30 days, reflecting an upward trend in search activity.

Indian Mutual Funds that invest in Viatris Stock (VTRS Ticker)

Name	Shares Held	Change in Shares	% of Assets
ICICI Prudential Value Discovery Fund Direct Plan Growth	8686950	3963334.07	1.22%
Motilal Oswal S&P 500 Index Fund Direct Growth	9940	-4.57	0.02%
ICICI Prudential MNC Fund Direct Growth	329126	-29308.67	1.47%

Global Institutional Holdings in Viatris

Vanguard Group Inc
12.20%
BlackRock Inc
8.18%
Davis Selected Advisers
5.28%
State Street Corp
5.18%
T. Rowe Price Associates, Inc.
4.95%
Pacer Advisors, INC.
2.96%

Analyst Recommendation on Viatris

Rating

Trend

Hold

7%Buy

57%Hold

35%Sell

Based on 14 Wall street analysts offering stock ratings for Viatris(by analysts ranked 0 to 5 stars)

Analyst Forecast on Viatris Stock (VTRS)

What analysts predicted

Upside of 41.7%

Target:

$11.75

Current:

$8.29

Insights on Viatris Stock (Ticker Symbol: VTRS)

Price Movement
In the last 6 months, VTRS stock has moved down by -36.6%
Decreasing Revenue
Revenue is down for the last 4 quarters, 3.79B → 3.25B (in $), with an average decrease of 5.0% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, 94.8M → -3.04B (in $), with an average decrease of 566.9% per quarter
VTRS vs HLN (1 yr)
In the last 1 year, Haleon Plc Spon Ads has given 30.7% return, outperforming this stock by 50.2%
Price to Sales
ForVTRS every $1 of sales, investors are willing to pay $0.7, whereas for Haleon Plc Spon Ads, the investors are paying $4.5 for every $1 of sales.

Viatris Technicals Summary

Sell

Neutral

Buy

Viatris is currently in a neutral trading position according to technical analysis indicators.

Viatris (VTRS) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Viatris Inc.	5.54%	-36.56%	-18.59%	-28.42%	-48.13%
Haleon Plc Spon Ads	7.23%	15.4%	31.92%	49.19%	49.19%
United Therapeutics Corporation	4.15%	-16.26%	13.13%	35.17%	73.61%
Zoetis Inc.	6.36%	-9.36%	-4.75%	-0.64%	24.18%
Neurocrine Biosciences Inc.	12.62%	-6.29%	-14.56%	34.77%	0.19%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Viatris Inc.	224.4	NA	0.14	2.21	-0.21	0.02	0.06	13.2
Haleon Plc Spon Ads	26.43	26.43	3.31	0.5	0.09	0.05	0.02	1.79
United Therapeutics Corporation	12.29	12.29	1.43	27.38	0.2	0.13	NA	151.02
Zoetis Inc.	29.08	29.08	2.76	6.23	0.52	0.15	0.01	10.44
Neurocrine Biosciences Inc.	40.38	40.38	0.27	6.12	0.12	0.09	NA	25.61

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Viatris Inc.	Hold	$10.0B	-48.13%	224.4	-26.45%
Haleon Plc Spon Ads	Buy	$50.0B	49.19%	26.43	12.84%
United Therapeutics Corporation	Buy	$13.9B	73.61%	12.29	40.44%
Zoetis Inc.	Buy	$72.1B	24.18%	29.08	27.12%
Neurocrine Biosciences Inc.	Buy	$11.8B	0.19%	40.38	12.68%

Viatris Dividend announcements

Viatris Dividends June, 2025
In the quarter ending June,2025. Viatris has declared dividend of $0.12

About Viatris

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also provides drugs in various therapeutic areas covering various noncommunicable and infectious diseases, including cardiovascular, CNS and anesthesia, dermatology, diabetes and metabolism, eye care, gastroenterology, immunology, oncology, and respiratory and allergy, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. In addition, the company offers medicines in the form of oral solid doses, injectables, and complex dosage forms to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. It distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. The company sells its products under the Lyrica, Lipitor, Celebrex, Viagra, Creon, Influvac, Wixela Inhub, EpiPen Auto-Injector, Fraxiparine, Yupelri, Norvasc, Amitiza, Effexor, Lipacreon, Zoloft, Xalabrands, Dymista, Xanax, and Breyna brands. It has collaboration agreements with Mapi Pharma Ltd. to develop and commercialize long-acting glatiramer acetate depot products and additional products; Revance Therapeutics, Inc. to develop, manufacture, and commercialize a biosimilar to the branded biologic product, BOTOX; and Theravance Biopharma, Inc. to develop and commercialize revefenacin. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.

Organization	Viatris
Employees	32000
CEO	Mr. Scott Andrew Smith Ph.D.
Industry	Health Technology

Management People of Viatris

Name	Title
Mr. Scott Andrew Smith Ph.D.	CEO & Director
Ms. Theodora Mistras	Chief Financial Officer
Mr. Paul B. Campbell	Chief Accounting Officer, Senior VP & Corporate Controller
Mr. Brian S. Roman	Chief Legal Officer
Dr. Corinne M. Le Goff M.B.A., Pharm.D.	Chief Commercial Officer
Mr. Ramkumar V. Rayapureddy	Chief Information Officer
Mr. Andrew Enrietti	Chief People Officer
Mr. Menassie Taddese M.B.A.	President of Emerging Markets
Mr. Derek Glover	Chief Quality Officer
Ms. Lara Ramsburg	Chief Corporate Affairs Officer

Important FAQs about investing in VTRS Stock from India :

Can Indians buy Viatris shares?

Yes, Indians can invest in the Viatris (VTRS) from India.

With INDmoney, you can buy Viatris at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Viatris at zero transaction cost.

How can I buy Viatris shares from India?

It is very easy to buy Viatris from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Viatris (VTRS) be purchased?

Yes, you can buy fractional shares of Viatris with INDmoney app.

What are the documents required to start investing in Viatris stocks?

To start investing in Viatris, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is Viatris share price today?

Viatris share price today stands at $8.29, Open: $8.27 ; Previous Close: $8.50 ; High: $8.30 ; Low: $8.20 ; 52 Week High: $13.55 ; 52 Week Low: $6.85.

The stock opens at $8.27, after a previous close of $8.50. The stock reached a daily high of $8.30 and a low of $8.20, with a 52-week high of $13.55 and a 52-week low of $6.85.